Generic opportunities outweigh challenges emanating across emerging markets: ICRA
Supported by acquisitions, geographic expansion and steadily expanding product portfolio, the top-10 pharma companies from India have achieved a CAGR of 21 per cent in revenues from emerging markets over the past five years16-09-2015